Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Free Cash Flow: 2020-2025

Historic Free Cash Flow for InMed Pharmaceuticals (INM) over the last 6 years, with Jun 2025 value amounting to -$7.8 million.

  • InMed Pharmaceuticals' Free Cash Flow rose 12.00% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.5 million, marking a year-over-year decrease of 13.70%. This contributed to the annual value of -$7.8 million for FY2025, which is 11.03% down from last year.
  • According to the latest figures from FY2025, InMed Pharmaceuticals' Free Cash Flow is -$7.8 million, which was down 11.03% from -$7.0 million recorded in FY2024.
  • Over the past 5 years, InMed Pharmaceuticals' Free Cash Flow peaked at -$7.0 million during FY2024, and registered a low of -$15.6 million during FY2022.
  • Moreover, its 3-year median value for Free Cash Flow was -$7.4 million (2023), whereas its average is -$7.4 million.
  • Per our database at Business Quant, InMed Pharmaceuticals' Free Cash Flow tumbled by 59.54% in 2022 and then surged by 52.36% in 2023.
  • Over the past 5 years, InMed Pharmaceuticals' Free Cash Flow (Yearly) stood at -$9.8 million in 2021, then slumped by 59.54% to -$15.6 million in 2022, then spiked by 52.36% to -$7.4 million in 2023, then rose by 6.02% to -$7.0 million in 2024, then decreased by 11.03% to -$7.8 million in 2025.